Abstract
The crystallographic structure of the FolB enzyme from Mycobacterium tuberculosis (MtFolB), complexed with its inhibitor 8-mercaptoguanine (8-MG), was elucidated at a resolution of 1.95 Å. A novel series of S8-functionalized 8-MG derivatives were synthesised and evaluated as in vitro inhibitors of dihydroneopterin aldolase (DHNA, EC 4.1.2.25) activity of MtFolB. These compounds exhibited IC50 values in the submicromolar range. Evaluation of the activity for five compounds indicated their inhibition mode and inhibition constants. Molecular docking analyses were performed to determine the enzyme-inhibitor intermolecular interactions and ligand conformations upon complex formation. The inhibitory activities of all compounds against the M. tuberculosis H37Rv strain were evaluated. Compound 3e exhibited a minimum inhibitory concentration in the micromolar range. Finally, Compound 3e showed no apparent toxicity in both HepG2 and Vero cells. The findings presented herein will advance the quest for novel, specific inhibitors targeting MtFolB, an attractive molecular target for TB drug development.
Keywords:
8-mercaptoguanine; Dihydroneopterin aldolase inhibitors; Mycobacterium tuberculosis; SAR.
MeSH terms
-
Aldehyde-Lyases* / antagonists & inhibitors
-
Aldehyde-Lyases* / chemistry
-
Aldehyde-Lyases* / metabolism
-
Animals
-
Antitubercular Agents* / chemical synthesis
-
Antitubercular Agents* / chemistry
-
Antitubercular Agents* / pharmacology
-
Chlorocebus aethiops
-
Crystallography, X-Ray
-
Dose-Response Relationship, Drug*
-
Enzyme Inhibitors* / chemical synthesis
-
Enzyme Inhibitors* / chemistry
-
Enzyme Inhibitors* / pharmacology
-
Guanine / analogs & derivatives
-
Guanine / chemical synthesis
-
Guanine / chemistry
-
Guanine / pharmacology
-
Hep G2 Cells
-
Humans
-
Microbial Sensitivity Tests*
-
Models, Molecular
-
Molecular Docking Simulation
-
Molecular Structure
-
Mycobacterium tuberculosis* / drug effects
-
Mycobacterium tuberculosis* / enzymology
-
Structure-Activity Relationship
-
Vero Cells
Substances
-
Antitubercular Agents
-
Enzyme Inhibitors
-
dihydroneopterin aldolase
-
Aldehyde-Lyases
-
Guanine
Grants and funding
This work was supported by Banco Nacional de Desenvolvimento Econômico e Social (BNDES) [grant number 14.2.0914.1] and the National Institute of Science and Technology on Tuberculosis (CNPq-FAPERGS-CAPES) [grant numbers: 421703–2017-2 and 17–1265-8]. C. V. Bizarro, L. A. Basso, and P. Machado are Research Career Awardees of the National Research Council of Brazil (CNPq). This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior, Brasil (CAPES), Finance Code 001.